Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Crizotinib
Crizotinib
877399-52-5
|
450.337
|
4.288
Crizotinib is a receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.
(R)-crizotinib | CZT | PF-02341066 | PF-2341066 | Xalkori | critozinib | crizotinib
Crizotinib is a receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.
(R)-crizotinib | CZT | PF-02341066 | PF-2341066 | Xalkori | critozinib | crizotinib
$19/5 mg
(EBC)
1
We provide 0 compound for Crizotinib
Powered by Bioz